Mount Sinai Innovation Partners
@MountSinai_IP
We facilitate the real-world application and commercialization of @MountSinaiNYC and @IcahnMountSinai discoveries and the development of research partnerships
ID:1479927060
http://www.ip.mountsinai.org 03-06-2013 15:18:00
2,8K Tweet
1,3K Takipçi
341 Takip Edilen
Sign up to receive innovation news, event updates, and information from Mount Sinai Innovation Partners. #IndustryInsights #TechTrends #ExclusiveEvents #NetworkingOpportunities
mountsinai.us6.list-manage.com/subscribe?u=c7…
Mark Lebwohl, MD, Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai, shares an overview of his research investigating the use of bimekizumab treatment for hepatic adverse events among patients with moderate to severe psoriasis.
Learn more Healio: healio.com/news/dermatolo…
Vivek Reddy, MD, Director, Cardiac Arrhythmia Service Mount Sinai Health System, comments on his study regarding the enhanced clinical capabilities of the Globe® System with right atrial ablation and hybrid energy ablation.
Learn more: businesswire.com/news/home/2024…
Researchers Icahn School of Medicine at Mount Sinai discuss their study about psychedelic drugs and how they can activate serotonin receptors to offer potential treatments for neuropsychiatric disorders.
Learn more: neurosciencenews.com/psychedelics-s…
Serdar Farhan, MD, Icahn School of Medicine at Mount Sinai, discusses his study regarding the use of less invasive endovascular treatments for patients with peripheral artery disease.
Learn more: tctmd.com/news/no-sex-sp…
Sign up to receive innovation news, event updates, and information from Mount Sinai Innovation Partners. #IndustryInsights #TechTrends #ExclusiveEvents #NetworkingOpportunities
mountsinai.us6.list-manage.com/subscribe?u=c7…
Mark Lebwohl, MD, Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai, shares an overview of his research investigating the use of bimekizumab treatment for hepatic adverse events among patients with moderate to severe psoriasis.
Learn more Healio: healio.com/news/dermatolo…
An international research team, including experts Icahn School of Medicine at Mount Sinai explain the ways that stress can result in major psychiatric conditions, such as depression.
Learn more: medicalxpress.com/news/2024-02-s…
Serdar Farhan, MD, Assistant Professor of Medicine and Cardiology at the Icahn School of Medicine at Mount Sinai, discusses his study that finds less invasive endovascular treatments work equally well in women as in men.
Learn more: usnews.com/news/health-ne…
We will be hosting our annual Demo Day of hashtag #ElementaLabs companies and other Mount Sinai companies and innovations on May 15! You'll learn about their healthcare products and have a chance to ask questions to company founders.
Sign up here: eventbrite.com/e/mount-sinai-…
Mark Lebwohl, MD, Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai, shares an overview of his research investigating the use of bimekizumab treatment for hepatic adverse events among patients with moderate to severe psoriasis.
Learn more Healio: healio.com/news/dermatolo…
Vivek Reddy, MD, Director of Cardiac Arrhythmia Services at the Icahn School of Medicine at Mount Sinai shares insight into his study regarding the use of pulsed field ablation catheters to isolate pulmonary veins in patients with paroxysmal atrial fibrillation.
Learn more: mims.com/specialty/topi…
We will be hosting our annual Demo Day of #ElementaLabs companies and other Mount Sinai companies and innovations on May 15! You'll learn about their healthcare products and have a chance to ask questions to company founders.
Sign up here: eventbrite.com/e/mount-sinai-…
Mark Lebwohl, MD, Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai, shares an overview of his research investigating the use of bimekizumab treatment for hepatic adverse events among patients with moderate to severe psoriasis.
Learn more Healio: healio.com/news/dermatolo…
